EA202091320A1 - LOCAL APPLICATION OF DIOXIDINE FOR INFECTIOUS INFLAMMATORY LESIONS OF THE EPITHELIUM - Google Patents

LOCAL APPLICATION OF DIOXIDINE FOR INFECTIOUS INFLAMMATORY LESIONS OF THE EPITHELIUM

Info

Publication number
EA202091320A1
EA202091320A1 EA202091320A EA202091320A EA202091320A1 EA 202091320 A1 EA202091320 A1 EA 202091320A1 EA 202091320 A EA202091320 A EA 202091320A EA 202091320 A EA202091320 A EA 202091320A EA 202091320 A1 EA202091320 A1 EA 202091320A1
Authority
EA
Eurasian Patent Office
Prior art keywords
epithelium
inflammatory lesions
dioxidine
infectious
local application
Prior art date
Application number
EA202091320A
Other languages
Russian (ru)
Inventor
Екатерина Константиновна Захарова
Original Assignee
Акционерное Общество "Валента Фармацевтика"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное Общество "Валента Фармацевтика" filed Critical Акционерное Общество "Валента Фармацевтика"
Publication of EA202091320A1 publication Critical patent/EA202091320A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к фармакологии, медицине и химико-фармацевтической промышленности, а именно к новому местному применению диоксидина (гидроксиметилхиноксалиндиоксида) в виде 0,001-0,4% раствора для лечения и/или профилактики инфекционно-воспалительных поражений эпителия. Также раскрыты лекарственное средство, фармацевтическая композиция и готовая лекарственная форма для лечения и/или профилактики инфекционно-воспалительных поражений эпителия, содержащие 0,001-0,4% раствор диоксидина, и набор для лечения и/или профилактики инфекционно-воспалительных поражений эпителия, содержащий флакон с вышеуказанным лекарственным средством, фармацевтической композицией или готовой лекарственной формой, по меньшей мере одну насадку и инструкцию по применению.The invention relates to pharmacology, medicine and the chemical-pharmaceutical industry, namely to a new local use of dioxidine (hydroxymethylquinoxalindoxide) in the form of a 0.001-0.4% solution for the treatment and / or prevention of infectious and inflammatory lesions of the epithelium. Also disclosed are a drug, a pharmaceutical composition and a finished dosage form for the treatment and / or prevention of infectious-inflammatory lesions of the epithelium, containing 0.001-0.4% dioxidine solution, and a kit for the treatment and / or prevention of infectious-inflammatory lesions of the epithelium, containing a vial with the aforementioned medicinal product, pharmaceutical composition or finished dosage form, at least one nozzle and instructions for use.

EA202091320A 2019-06-24 2020-06-23 LOCAL APPLICATION OF DIOXIDINE FOR INFECTIOUS INFLAMMATORY LESIONS OF THE EPITHELIUM EA202091320A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2019119666A RU2726982C1 (en) 2019-06-24 2019-06-24 Local application of dioxydine in infectious-inflammatory epithelial affection

Publications (1)

Publication Number Publication Date
EA202091320A1 true EA202091320A1 (en) 2020-12-30

Family

ID=71616362

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091320A EA202091320A1 (en) 2019-06-24 2020-06-23 LOCAL APPLICATION OF DIOXIDINE FOR INFECTIOUS INFLAMMATORY LESIONS OF THE EPITHELIUM

Country Status (2)

Country Link
EA (1) EA202091320A1 (en)
RU (1) RU2726982C1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2246292C2 (en) * 2003-04-22 2005-02-20 Барбинов Вячеслав Витальевич External agent for prophylaxis of skin infectious disease and method for prophylaxis
RU2545798C1 (en) * 2014-03-24 2015-04-10 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Pharmaceutical composition for immediate treatment of burns of various origins, area and depth in form of spray, gel and aerosol
RU2682171C2 (en) * 2016-10-11 2019-03-15 Закрытое Акционерное Общество "Биологические Исследования И Системы" (Зао "Бис") Pharmaceutical combined composition for the treatment of purulent wounds on the basis of fluoroquinolons (options)
RU2667974C2 (en) * 2016-10-11 2018-09-25 Закрытое Акционерное Общество "Биологические Исследования И Системы" (Зао "Бис") Pharmaceutical combined composition for local and external use on basis of dioxidine

Also Published As

Publication number Publication date
RU2726982C1 (en) 2020-07-17

Similar Documents

Publication Publication Date Title
MX2021004431A (en) Novel processes.
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
UY30535A1 (en) COMPOSITION UNDERSTANDING ANTIRRETROVIRAL PHARMACOS AND AT LEAST AN INSOLUBLE WATER POLYMER, PREPARATION PROCESS AND APPLICATIONS.
EA202191239A1 (en) COMPOUNDS AND THEIR APPLICATION FOR TREATMENT OF 1-ANTITRIPSIN DEFICIENCY
BR112012030641A2 (en) methods and compositions for oral pharmaceutical therapy
AR099299A1 (en) INHIBITOR OF THE CHOLESTERILE ESTER TRANSFER PROTEIN (CETP) AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
EA202091320A1 (en) LOCAL APPLICATION OF DIOXIDINE FOR INFECTIOUS INFLAMMATORY LESIONS OF THE EPITHELIUM
ECSP22092205A (en) LEVILIMAB AQUEOUS PHARMACEUTICAL COMPOSITION AND ITS USE
ATE480526T1 (en) RITONAVIR ANALOGUE COMPOUND SUITABLE AS A RETROVIRAL PROTEASE INHIBITOR, PREPARATION OF THE RITONAVIR ANALOGUE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE RITONAVIR ANALOGUE COMPOUND
CO2023002650A2 (en) Solid dosage forms of palbociclib
WO2018069805A3 (en) Method for preparation of liquid oral composition of l-thyroxin
EA202091319A1 (en) LOCAL APPLICATION OF DIOXIDINE FOR INFECTIOUS INFLAMMATORY DISEASES OF THE GENITAL ORGANS AND PELVIC ORGANS
DOP2021000069A (en) DERIVATIVES OF 4 PIRAZIN-2-ILMETIL-MORFOLINA AND THEIR USE AS A MEDICINAL PRODUCT
BR112018009476A8 (en) plasminogen dosage regimen for wound healing
BR112018008835A8 (en) oral pharmaceutical composition, oral pulsatile release pharmaceutical composition, method for treating a disease condition requiring dimethyl fumarate therapy and method for treating multiple sclerosis
BR112022021166A2 (en) INNOVATIVE COMPOUND [2-(DIMETHYLAMINO)-2-PHENYLBUTYL]-3,4,5-TRIMETHOXYBENZOATE 4-METHYL-2H-CROMEN-2-ON-7-IL SULPHATE AND USE OF IT
JOP20220045A1 (en) Aqueous pharmaceutical composition of anti-pd1 antibody prolgolimab and use thereof
EA202191124A1 (en) DOSAGE FORM FOR TREATMENT AND PREVENTION OF INFLUENZA AND ARVI
AR108792A1 (en) COMPOSITIONS THAT INCLUDE TIMOLOL
EA202091321A1 (en) LOCAL APPLICATION OF DIOXIDINE FOR INFECTIOUS INFLAMMATORY DISEASES OF THE ORAL CAVITY
EA202090135A1 (en) NEW COMPOSITIONS OF 2- (IMIDAZOL-4-YL) ETHANAMIDE PENTANDIOVIC-1,5 ACID FOR TREATMENT AND PREVENTION OF VIRAL DISEASES
EA202091903A1 (en) CRYSTAL FORM OF BITEGAVIR-SODIUM
EA202000300A1 (en) PHARMACEUTICAL KIT FOR COMBINED THERAPY FOR COVID-19 (SARS-CoV-2) AND METHOD FOR ITS USE
CO2023014166A2 (en) Pharmaceutical composition of pembrolizumab and its use
EA201900293A2 (en) TRANSDERMAL DRUG FOR TREATMENT AND PREVENTION OF DISEASES OF JOINTS AND SOFT TISSUES